Typicality: | 0.538 |
Saliency: | 0.371 |
to payors | 11 | transitive-object |
to pbms | 8 | transitive-object |
rebate → be paid by → pharmaceutical manufacturers | 7 |
rebate → be paid by → drug manufacturers | 6 |
rebate → be offered by → drug manufacturers | 5 |
rebate → be paid by → drug companies | 3 |
negative | neutral | positive |
0.235 | 0.699 | 0.066 |
Raw frequency | 21 |
Normalized frequency | 0.371 |
Modifier score | 0.900 |
Perplexity | 228.361 |